SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

A sharp rebound above the 200-day moving average has traders debating whether AVAX is beginning a broader altcoin breakout, with bullish participants citing Avalanches institutional-access and tokenization narrative. Skeptics argue the move lacks volume and buying support, making another pump-and-selloff possible.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Traders are focused on the potential U.S. Clarity Act and related SEC/CFTC rulemaking, alongside speculation that Stellar could benefit from institutional tokenization and payments adoption through DTCC, MoneyGram, and bank initiatives. Bulls view these developments as a long-term catalyst, while skeptics argue XLM has lagged and that the adoption narrative has fueled repeated pump-and-dump cycles.

Lighter is a decentralized trading platform built for unmatched security and scale. It’s the first exchange to offer verifiable order matching and liquidations while delivering best-in-class performance on par with traditional exchanges.

lighter

Attention is centered on Lighters integration with Robinhood Chain for perpetual-futures trading, rising trading activity, and revenue-funded LIT buybacks and token burns. Traders are broadly bullish on the protocols growth and deflationary tokenomics, though some warn about upcoming unlocks, profit-taking, and the risk of a pullback after the sharp rally.

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The Hunter Biden-themed memecoin drew attention after a rapid post-launch collapse, with traders broadly describing it as a rug pull or speculative scam amid thin liquidity. A smaller group is still buying the dip or anticipating a rebound, while others are shorting it and expecting further losses.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Kylian Mbapps departure from Nike after nearly two decades to join On is driving debate over whether the loss weakens Nikes soccer positioning or reduces costly endorsement spending. The discussion is compounded by persistent lows and concern about Nikes turnaround ahead of its upcoming earnings report, though some traders view the selloff as an opportunity to accumulate.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Unconfirmed Big Pharma acquisition speculation, including possible Lilly or AstraZeneca interest, is the dominant catalyst around ABVX, with traders also watching upcoming obefazimod regulatory and Crohns milestones. The community is divided between bulls expecting a takeover and bears arguing that the lack of a confirmed deal, competitive pressures, and clinical risk could leave the stock range-bound.

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Arbutuss modified Dutch-auction share repurchase is driving attention, with traders focused on the tender process, clearing price, proration risk and the effect of retiring a substantial portion of shares. Some view the buyback as a valuation floor and increased ownership for remaining holders, while others worry it uses settlement proceeds, limits Hepatitis B investment and could make a future acquisition easier for Roivant; Pfizer litigation and pipeline prospects remain longer-term considerations.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Auvelitys launch for Alzheimers-related agitation is the dominant focus, with traders highlighting rising new prescriptions, strong uptake among older patients, and analyst views that early demand may be understated by samples and long-term-care data gaps. Bulls see accelerating commercial momentum, while others remain concerned about relatively flat weekly prescription reports, thin-volume selling, and broader biotech-sector pressure.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Recent strong quarterly execution, continued profitability and analyst upgrades are driving attention, reinforced by Pagayas auto-loan forward-flow agreement with Neuberger and perceived institutional accumulation. Bulls view the AI-lending platform as deeply undervalued with improving funding demand, while skeptics point to interest-rate sensitivity, macroeconomic pressure, dilution concerns and volatile short-driven trading.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

Traders are attributing NEARs sharp rally to the launch of privacy-focused perpetual contracts powered by Hyperliquid, reinforcing its broader AI, privacy, and cross-chain infrastructure narrative. The move has sparked bullish enthusiasm and short-squeeze speculation, although some traders view it as a liquidity-driven pump and expect a pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
